Cargando…

Lack of Histamine H(4)-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice

Inflammatory bowel diseases (IBD) are a growing health problem worldwide, severely affecting patients’ life qualities and life expectancies. Therapeutic options, which are rare and focus on symptoms associated with the disease, suffer from increasing numbers of patients refractory to the established...

Descripción completa

Detalles Bibliográficos
Autores principales: Wunschel, Eva J., Schirmer, Bastian, Seifert, Roland, Neumann, Detlef
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601386/
https://www.ncbi.nlm.nih.gov/pubmed/28955241
http://dx.doi.org/10.3389/fphar.2017.00642
_version_ 1783264376806965248
author Wunschel, Eva J.
Schirmer, Bastian
Seifert, Roland
Neumann, Detlef
author_facet Wunschel, Eva J.
Schirmer, Bastian
Seifert, Roland
Neumann, Detlef
author_sort Wunschel, Eva J.
collection PubMed
description Inflammatory bowel diseases (IBD) are a growing health problem worldwide, severely affecting patients’ life qualities and life expectancies. Therapeutic options, which are rare and focus on symptoms associated with the disease, suffer from increasing numbers of patients refractory to the established strategies. Thus, in order to generate new therapeutic regimens, the detailed understanding of the pathogenic mechanisms causing IBD is necessary. Histamine is an inflammatory mediator associated with IBD. Four histamine receptors are currently known of which the histamine H(4)-receptor (H(4)R) has been shown to possess a pro-inflammatory function in several experimental models of inflammatory diseases, including dextran sodium sulfate (DSS)-induced colitis in mice. No single model reflects the complexity of human IBD, but each model provides valuable information on specific aspects of IBD pathogenesis. While DSS-induced colitis mostly relies on innate immune mechanisms, trinitrobenzene sulfonic acid (TNBS)-induced colitis rather reflects T-cell mechanisms. Consequently, an observation made in a single model has to be verified in at least one other model. Therefore, in the present study we investigated the effect of genetic blockade of H(4)R-signaling in mice subjected to the model of TNBS-induced acute colitis. We analyzed severity and progression of clinical signs of colitis, as well as histopathologic alterations in the colon and local cytokine production. Genetic ablation of H(4)R expression worsened clinical signs of acute colitis and histological appearance of colon inflammation after TNBS application. Moreover, TNBS instillation enhanced local synthesis of inflammatory mediators associated with a neutrophilic response, i.e., CXCL1, CXCL2, and interleukin-6. Lastly, also myeloperoxidase concentration, indicative for the presence of neutrophils, was elevated in cola of TNBS-treated mice due to the absence of H(4)R expression. Our results indicate an anti-inflammatory role of histamine via H(4)R in TNBS-induced acute neutrophilic colitis in mice, thus questioning the strategy of pharmacological H(4)R blocked as new therapeutic option for patients suffering from IBD.
format Online
Article
Text
id pubmed-5601386
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56013862017-09-27 Lack of Histamine H(4)-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice Wunschel, Eva J. Schirmer, Bastian Seifert, Roland Neumann, Detlef Front Pharmacol Pharmacology Inflammatory bowel diseases (IBD) are a growing health problem worldwide, severely affecting patients’ life qualities and life expectancies. Therapeutic options, which are rare and focus on symptoms associated with the disease, suffer from increasing numbers of patients refractory to the established strategies. Thus, in order to generate new therapeutic regimens, the detailed understanding of the pathogenic mechanisms causing IBD is necessary. Histamine is an inflammatory mediator associated with IBD. Four histamine receptors are currently known of which the histamine H(4)-receptor (H(4)R) has been shown to possess a pro-inflammatory function in several experimental models of inflammatory diseases, including dextran sodium sulfate (DSS)-induced colitis in mice. No single model reflects the complexity of human IBD, but each model provides valuable information on specific aspects of IBD pathogenesis. While DSS-induced colitis mostly relies on innate immune mechanisms, trinitrobenzene sulfonic acid (TNBS)-induced colitis rather reflects T-cell mechanisms. Consequently, an observation made in a single model has to be verified in at least one other model. Therefore, in the present study we investigated the effect of genetic blockade of H(4)R-signaling in mice subjected to the model of TNBS-induced acute colitis. We analyzed severity and progression of clinical signs of colitis, as well as histopathologic alterations in the colon and local cytokine production. Genetic ablation of H(4)R expression worsened clinical signs of acute colitis and histological appearance of colon inflammation after TNBS application. Moreover, TNBS instillation enhanced local synthesis of inflammatory mediators associated with a neutrophilic response, i.e., CXCL1, CXCL2, and interleukin-6. Lastly, also myeloperoxidase concentration, indicative for the presence of neutrophils, was elevated in cola of TNBS-treated mice due to the absence of H(4)R expression. Our results indicate an anti-inflammatory role of histamine via H(4)R in TNBS-induced acute neutrophilic colitis in mice, thus questioning the strategy of pharmacological H(4)R blocked as new therapeutic option for patients suffering from IBD. Frontiers Media S.A. 2017-09-13 /pmc/articles/PMC5601386/ /pubmed/28955241 http://dx.doi.org/10.3389/fphar.2017.00642 Text en Copyright © 2017 Wunschel, Schirmer, Seifert and Neumann. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wunschel, Eva J.
Schirmer, Bastian
Seifert, Roland
Neumann, Detlef
Lack of Histamine H(4)-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice
title Lack of Histamine H(4)-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice
title_full Lack of Histamine H(4)-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice
title_fullStr Lack of Histamine H(4)-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice
title_full_unstemmed Lack of Histamine H(4)-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice
title_short Lack of Histamine H(4)-Receptor Expression Aggravates TNBS-Induced Acute Colitis Symptoms in Mice
title_sort lack of histamine h(4)-receptor expression aggravates tnbs-induced acute colitis symptoms in mice
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5601386/
https://www.ncbi.nlm.nih.gov/pubmed/28955241
http://dx.doi.org/10.3389/fphar.2017.00642
work_keys_str_mv AT wunschelevaj lackofhistamineh4receptorexpressionaggravatestnbsinducedacutecolitissymptomsinmice
AT schirmerbastian lackofhistamineh4receptorexpressionaggravatestnbsinducedacutecolitissymptomsinmice
AT seifertroland lackofhistamineh4receptorexpressionaggravatestnbsinducedacutecolitissymptomsinmice
AT neumanndetlef lackofhistamineh4receptorexpressionaggravatestnbsinducedacutecolitissymptomsinmice